Global Nasal Spray Market Share and Growth Rate 2025 | Top Key Players AptarGroup, Inc., Pfizer, Catalent, Sandoz International GmbH, Mylan, Adapt Pharma, Inc, Innovus Pharmaceuticals, Valeant Pharmaceuticals, Others

According to Data Bridge Market Research new Market report, “Global Nasal Spray Market By Product Type (Decongestion Nasal Spray, Salt Water Solution/ Saline Nasal Spray, Steroid Nasal Spray), By Container Design (Pressurized Canisters, Pump Bottles), By Dosage form (Unit/Single dose, Bi-Dose, Multi-Dose), By Prescription (Prescribed, Over-The-Counter), By Therapeutic Class (Antihistamine, Nasal Steroids, Mast Cell Inhibitor, Anticholinergic), By Application (Allergic, Non-Allergic Rhinitis, Nasal Congestion, CNS Disorders, Vaccination, Others), By End-User (Hospitals, Clinics, Home Care Settings, Pharmacies, Community Health Care), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast is projected to reach USD 21.87 billion by 2025, at a CAGR of 7.0% during the forecast period of 2018 to 2025.

Download exclusive PDF sample report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-nasal-spray-market

Global Nasal Spray Market

Nasal sprays are used for the treatment of nasal congestion and infections. They are also used effectively in the treatment of paranasal sinuses such as allergic & non-allergic sinusitis & rhinitis. To solve the problem of degradation of the drug before reaching the target site, to solve the problem of slow absorption and poor bioavailability the nasal drug delivery technique is used. The key players are focusing on growth strategies such as geographical expansion and acquisitions, new product launch, R&D development for the growth of the market. For instance, In October 2016, Adapt Pharma received Health Canada approval for its naloxone hydrochloride nasal spray, which is used for the treatment of opioid overdose.

According to asthma allergy foundation of America, allergic rhinitis affects 6.1 million of the children population and 20 million of the adult population in United States.

According to statista, in 2015, the second leading nasal spray brand of the United States was Afrin, which amounted the sales of approximately 55.9 million USD.

Get 10% Discount Instant Mail us @ sopan.gedam@databridgemarketresearch.com

Segmentation: Global Nasal Spray Market

The global market for nasal spray by the following sub-categories is presented

By Product Type

• Decongestion Nasal Spray
• Salt Water Solution/
• Steroid Nasal Spray

By Container Design

• Pressurized Canisters
• Pump Bottles

By Dosage Form

• Unit/Single dose
• Bi-Dose
• Multi-Dose

By Prescription

• Prescribed
• Over-The-Counter

By Therapeutic Class

• Antihistamine
• Nasal Steroids
• Mast Cell Inhibitor
• Anticholinergic

By Application

• Allergic
• Non-Allergic Rhinitis
• Nasal Congestion
• CNS Disorders
• Vaccination
• Others

By End-User

• Hospitals
• Clinics
• Home Care Settings
• Pharmacies
• Community Health Care

By Geography

• North America
• South America
• Europe
• Asia-Pacific
• Middle East and Africa

Order a copy of Global Nasal Spray Market Report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-nasal-spray-market

FACTORS DRIVING GROWTH IN THE GLOBAL NASAL SPRAY MARKET

Increasing cases of allergic rhinitis and infections:

It is found that allergic rhinitis affects 10 to 30% of children and adults in the U.S. and other countries. Prevalence of allergic rhinitis is countries such as Australia, New Zealand and the United Kingdom is more. According to National Center for Biotechnology Information 2016, In India more than 20-30% of the population was affected with an allergic rhinitis. This allergic disorder is increasing rapidly from past two decades. It was found that every 1 out of 2 individual is affected by it.

Allergic rhinitis is a global health problem also with economic & societal burdens. About 40.0 % of the world’s population is suffering from this condition. The reported incidence of the allergic rhinitis in western countries is 1.4%-39.7%.

Hence, with the increasing incidences of the nasal infection, respiratory diseases, allergic rhinitis, paranasal sinuses globally, the nasal spray market is expected to achieve the inclining growth due to certain advantages such as self-administration, improvement in patient compliance and painless drug delivery.

Rising level of pollution:

According to a research article published by the Atlanta healthcare, it has been observed that breathing in polluted air could increase the risk of sinus problems. The quality of air in your city can make the difference in your breathing and health issues. The main reason behind asthma, breathing problem, heart and lung diseases, sinus pain, sinus headache, allergy and chronic sinus problems is increasing air pollution. There are various pollutants present in air such as carbon monoxide, nitrogen oxide, sulphur dioxide, which cause air pollution. Many researchers have found that increase in air pollution also increases the risk of chronic sinusitis.

According to the study published in the American Journal of Respiratory Cell and Molecular Biology, researchers have found that there is breakdown in the integrity of nasal air passage and sinus due to the intake of polluted air. Hence, people living in Delhi, which is the highest polluted city in India, are more exposed to chronic sinus problems. The world health organization, in 2016, said that 92% of the world’s population lives in places where air quality levels are beyond WHO safety limits. They also claimed that around three million deaths a year are due to exposure to outdoor air pollution.

With the increase in development of industries, automotive sector, construction, deforestation the pollution is increasing every year, which is creating various respiratory issues, as well as allergic disorders, sinus problems. All these factors are creating opportunities for the growth of the market.

Some of the major market players in this market are Cipla Inc., Maya Biotech, Aurena, Premier Filling Company, Inc, Sandoz International GmbH, Catalent, Inc, Pfizer Inc, AptarGroup, Inc, ADAPT Pharma, Inc, Mylan N.V, INNOVUS PHARMACEUTICALS, INC, Valeant., ALLERGAN, Nephron Pharmaceuticals Corporation, Meda pharmaceuticals, Inc, Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, Apotex Inc., Novartis AG among others.

Speak to Our Experts @ https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-nasal-spray-market

Table of Contents:

1. INTRODUCTION
1.1. OVERVIEW OF THE GLOBAL NASAL SPRAY MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
1.2.3. STAKEHOLDERS
2. RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL NASAL SPRAY MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6. PORTER’S FIVE FORCES MATRIX
2.3. GLOBAL NASAL SPRAY MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. GLOBAL NASAL SPRAY MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.1.1. IMPROVING PATIENT COMPLIANCE AND ACCEPTIBILITY
4.3.1.2. EFFECTIVENESS OVER OTHER FORMS OF DRUG DELIVERY
4.3.2. RESTRAINTS
4.3.2.1. DRUG FAILURES
4.3.2.2. COMPLIANCE OF INHALING NASAL SPRAYS
4.3.3. OPPURTUNITIES
4.3.3.1. RISING DEMAND FOR SELF ADMINISTRATIVE DRUG DELIVERY
4.3.3.2. EXPANDING THERAPEUTIC APPLICATIONS FOR NASAL SPRAYS
4.3.4. THREATS
4.3.4.1. PRODUCT RECALLS
4.3.4.2. REGULATORY HURDLES
4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5. NASAL SPRAY MARKET, BY PRODUCT TYPE
5.1. OVERVIEW
5.2. DECONGESTION NASAL SPRAY
5.3. SALT WATER SOLUTION/ SALINE NASAL SPRAY
5.4. STEROID NASAL SPRAY
6. NASAL SPRAY MARKET, BY CONTAINER DESIGN
6.1. OVERVIEW
6.2. PRESSURIZED CANISTERS
6.3. PUMP BOTTLES
7. NASAL SPRAY MARKET, BY DOSAGE FORM
7.1. OVERVIEW
7.2. UNIT/SINGLE DOSE
7.3. BI DOSE
7.4. MULTI DOSE
8. NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY
8.1. OVERVIEW
8.2. PRESCRIBED
8.3. OVER THE COUNTER
9. NASAL SPRAY MARKET, BY THERAPEUTIC CLASS
9.1. OVERVIEW
9.2. ANTIHISTAMINE
9.3. NASAL STEROIDS
9.4. MAST CELL INHIBITOR
9.5. ANTICHOLINERGIC
10. NASAL SPRAY MARKET, BY APPLICATION
10.1. OVERVIEW
10.2. ALLERGIC AND NON-ALLERGIC RHINITIS
10.3. NASAL CONGESTION
10.4. CENTRAL NERVOUS SYSTEM DISORDERS
10.5. VACCINATION
10.6. OTHERS
11. NASAL SPRAY MARKET, BY END USER
11.1. OVERVIEW
11.2. HOSPITALS
11.3. CLINICS
11.4. HOME CARE SETTINGS
11.5. PHARMACIES
11.6. COMMUNITY HEALTH CARE
12. NASAL SPRAY MARKET, BY GEOGRAPHY
12.1. COUNTRYWISE NASAL SPRAY MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
12.1.1. NORTH AMERICA
12.1.1.1. U.S.
12.1.1.2. CANADA
12.1.1.3. MEXICO
12.1.2. EUROPE
12.1.2.1. GERMANY
12.1.2.2. FRANCE
12.1.2.3. U.K.
12.1.2.4. ITALY
12.1.2.5. SPAIN
12.1.2.6. RUSSIA
12.1.2.7. TURKEY
12.1.2.8. BELGIUM
12.1.2.12. NETHERLANDS
12.1.2.13. SWITZERLAND
12.1.2.14. REST OF EUROPE
12.1.3. ASIA-PACIFIC (APAC)
12.1.3.1. JAPAN
12.1.3.2. CHINA
12.1.3.3. SOUTH KOREA
12.1.3.4. INDIA
12.1.3.5. AUSTRALIA
12.1.3.6. SINGAPORE
12.1.3.7. THAILAND
12.1.3.8. MALAYSIA
12.1.3.12. INDONESIA
12.1.3.13. PHILIPPINES
12.1.3.14. REST OF APAC
12.1.4. LATIN AMERICA
12.1.4.1. BRAZIL
12.1.4.2. REST OF LATIN AMERICA
12.1.5. MIDDLE EAST AND AFRICA
12.1.5.1. SOUTH AFRICA
12.1.5.2. REST OF MIDDLE EAST AND AFRICA
12.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
13. NASAL SPRAY MARKET: COMPETITIVE LANDSCAPE
13.1. GLOBAL NASAL SPRAY MARKET: COMPANY SHARE ANALYSIS
13.2. U.S. NASAL SPRAY MARKET: COMPANY SHARE ANALYSIS
13.3. EUROPE NASAL SPRAY MARKET: COMPANY SHARE ANALYSIS
13.4. APAC NASAL SPRAY MARKET: COMPANY SHARE ANALYSIS
13.5. SOUTH AMERICA NASAL SPRAY MARKET: COMPANY SHARE ANALYSIS
13.6. MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: COMPANY SHARE ANALYSIS
13.7. MERGERS & ACQUISITIONS
13.8. NEW PRODUCT DEVELOPMENT & APPROVALS
13.9. EXPANSIONS
13.10. REGULATORY CHANGES
13.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
14. NASAL SPRAY MARKET, COMPANY PROFILES
14.1. SANDOZ INTERNATIONAL
14.1.1 COMPANY OVERVIEW
14.1.2 SWOT ANALYSIS
14.1.3 REVENUE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPEMENTS
14.1.5 DATA BRIDGE ANALYSIS
14.2. CATALENT
14.2.1 COMPANY OVERVIEW
14.2.2 SWOT ANALYSIS
14.2.3 REVENUE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPEMENTS
14.2.5 DATA BRIDGE ANALYSIS
14.3. PFIZER, INC.
14.3.1 COMPANY OVERVIEW
14.3.2 SWOT ANALYSIS
14.3.3 REVENUE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPEMENTS
14.3.5 DATA BRIDGE ANALYSIS
14.4. PFEIFFER GMBH
14.4.1 COMPANY OVERVIEW
14.4.2 SWOT ANALYSIS
14.4.3 REVENUE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPEMENTS
14.4.5 DATA BRIDGE ANALYSIS
14.5. NASTECH PHARMACEUTICAL
14.5.1 COMPANY OVERVIEW
14.5.2 SWOT ANALYSIS
14.5.3 REVENUE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPEMENTS
14.5.5 DATA BRIDGE ANALYSIS
14.6. ADAPT PHARMA, INC.
14.6.1 COMPANY OVERVIEW
14.6.2 SWOT ANALYSIS
14.6.3 REVENUE ANALYSIS
14.6.4 PRODUCT PORTFOLIO
14.6.5 RECENT DEVELOPEMENTS
14.6.5 DATA BRIDGE ANALYSIS
14.7. MYLAN N.V.
14.7.1 COMPANY OVERVIEW
14.7.2 SWOT ANALYSIS
14.7.3 REVENUE ANALYSIS
14.7.4 PRODUCT PORTFOLIO
14.7.5 RECENT DEVELOPEMENTS
14.7.5 DATA BRIDGE ANALYSIS
14.8. INNOVUS PHARMACEUTICALS
14.8.1 COMPANY OVERVIEW
14.8.2 SWOT ANALYSIS
14.8.3 REVENUE ANALYSIS
14.8.4 PRODUCT PORTFOLIO
14.8.5 RECENT DEVELOPEMENTS
14.8.5 DATA BRIDGE ANALYSIS
14.9. ALLERGAN PLC
14.9.1 COMPANY OVERVIEW
14.9.2 SWOT ANALYSIS
14.9.3 REVENUE ANALYSIS
14.9.4 PRODUCT PORTFOLIO
14.9.5 RECENT DEVELOPEMENTS
14.9.5 DATA BRIDGE ANALYSIS
14.10. NEPHRON PHARMACEUTICALS CORPORATION
14.10.1 COMPANY OVERVIEW
14.10.2 SWOT ANALYSIS
14.10.3 REVENUE ANALYSIS
14.10.4 PRODUCT PORTFOLIO
14.10.5 RECENT DEVELOPEMENTS
14.10.5 DATA BRIDGE ANALYSIS
14.11. CIPLA LTD
14.11.1 COMPANY OVERVIEW
14.11.2 SWOT ANALYSIS
14.11.3 REVENUE ANALYSIS
14.11.4 PRODUCT PORTFOLIO
14.11.5 RECENT DEVELOPEMENTS
14.11.5 DATA BRIDGE ANALYSIS
14.12. MEDA PHARMACEUTICALS, INC.
14.12.1 COMPANY OVERVIEW
14.12.2 SWOT ANALYSIS
14.12.3 REVENUE ANALYSIS
14.12.4 PRODUCT PORTFOLIO
14.12.5 RECENT DEVELOPEMENTS
14.12.5 DATA BRIDGE ANALYSIS
14.13. SUNOVION PHARMACEUTICALS INC.
14.13.1 COMPANY OVERVIEW
14.13.2 SWOT ANALYSIS
14.13.3 REVENUE ANALYSIS
14.13.4 PRODUCT PORTFOLIO
14.13.5 RECENT DEVELOPEMENTS
14.13.5 DATA BRIDGE ANALYSIS
14.14. TEVA RESPIRATORY, LLC.
14.14.1 COMPANY OVERVIEW
14.14.2 SWOT ANALYSIS
14.14.3 REVENUE ANALYSIS
14.14.4 PRODUCT PORTFOLIO
14.14.5 RECENT DEVELOPEMENTS
14.14.5 DATA BRIDGE ANALYSIS
14.15. APOTEX CORP.
14.15.1 COMPANY OVERVIEW
14.15.2 SWOT ANALYSIS
14.15.3 REVENUE ANALYSIS
14.15.4 PRODUCT PORTFOLIO
14.15.5 RECENT DEVELOPEMENTS
14.15.5 DATA BRIDGE ANALYSIS
15. APPENDIX
15.1. RELATED REPORTS
15.2. CUSTOMIZABLE OPTIONS
15.3. SOURCE SHEET
16. ABOUT DATA BRIDGE MARKET RESEARCH

View Full Report @ https://databridgemarketresearch.com/reports/global-nasal-spray-market

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Sopan Gedam
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.